Literature DB >> 35618450

Author response.

Brendan C Delaney1, Clare Rayner2, Anette Freyer3, Sharon Taylor4, Linn Järte5, Nathalie MacDermott6, Martine Nurek7.   

Abstract

Entities:  

Year:  2022        PMID： 35618450      PMCID： PMC9172222          DOI： 10.3399/bjgp22X719549

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   6.302


× No keyword cloud information.
  4 in total

1.  Endothelial dysfunction in acute and long standing COVID-19: A prospective cohort study.

Authors:  Evangelos Oikonomou; Nektarios Souvaliotis; Stamatios Lampsas; Gerasimos Siasos; Garyphallia Poulakou; Panagiotis Theofilis; Theodore G Papaioannou; Anna-Bettina Haidich; Georgia Tsaousi; Vasileios Ntousopoulos; Vissaria Sakka; Georgios Charalambous; Vasiliki Rapti; Sylvia Raftopoulou; Konstantinos Syrigos; Costas Tsioufis; Dimitris Tousoulis; Manolis Vavuranakis
Journal:  Vascul Pharmacol       Date:  2022-03-03       Impact factor: 5.773

Review 2.  A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications.

Authors:  Douglas B Kell; Gert Jacobus Laubscher; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-02-17       Impact factor: 3.857

Review 3.  Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.

Authors:  Amy D Proal; Michael B VanElzakker
Journal:  Front Microbiol       Date:  2021-06-23       Impact factor: 5.640

4.  Mast cell activation symptoms are prevalent in Long-COVID.

Authors:  Leonard B Weinstock; Jill B Brook; Arthur S Walters; Ashleigh Goris; Lawrence B Afrin; Gerhard J Molderings
Journal:  Int J Infect Dis       Date:  2021-09-23       Impact factor: 3.623
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.